William M. Crist
#154,097
Most Influential Person Now
William M. Crist's AcademicInfluence.com Rankings
William M. Cristphilosophy Degrees
Philosophy
#8652
World Rank
#12068
Historical Rank
Logic
#5678
World Rank
#7095
Historical Rank
William M. Cristbiology Degrees
Biology
#11738
World Rank
#15160
Historical Rank
Genetics
#1277
World Rank
#1379
Historical Rank
Molecular Biology
#1838
World Rank
#1867
Historical Rank
Biochemistry
#1952
World Rank
#2093
Historical Rank
Download Badge
Philosophy Biology
William M. Crist's Degrees
- PhD Molecular Biology Stanford University
- Doctorate Medicine Stanford University
Why Is William M. Crist Influential?
(Suggest an Edit or Addition)William M. Crist's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Expression of a multidrug resistance gene in human cancers. (1989) (1238)
- The Third Intergroup Rhabdomyosarcoma Study. (1995) (901)
- Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. (2001) (888)
- Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. (1996) (881)
- The intergroup rhabdomyosarcoma study‐I. A final report (1988) (807)
- The intergroup rhabdomyosarcoma study‐II (1993) (677)
- PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. (2002) (654)
- Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. (1991) (401)
- Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV. (2003) (398)
- Non-Hodgkin's lymphoma in childhood. (1996) (389)
- Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy (1991) (389)
- Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. (1990) (387)
- Rhabdomyosarcoma and Undifferentiated Sarcoma in the First Two Decades of Life: A Selective Review of Intergroup Rhabdomyosarcoma Study Group Experience and Rationale for Intergroup Rhabdomyosarcoma Study V (2001) (353)
- The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix‐loop‐helix protein. (1990) (331)
- Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. (1993) (322)
- Site‐specific recombination of the tal‐1 gene is a common occurrence in human T cell leukemia. (1990) (316)
- Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. (1993) (310)
- Biology and therapy of pediatric rhabdomyosarcoma. (1995) (283)
- Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases. (1991) (278)
- Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee. (1990) (258)
- Biology and treatment of infant leukemias. (1995) (235)
- Ewing's sarcoma of soft tissues in childhood: a report from the Intergroup Rhabdomyosarcoma Study, 1972 to 1991. (1997) (227)
- The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment Protocols (2001) (223)
- Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group. (1999) (215)
- Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study (1990) (214)
- Intergroup Rhabdomyosarcoma Study: Update for Pathologists (1998) (209)
- Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study. (1992) (207)
- Age is an independent prognostic factor in rhabdomyosarcoma: A report from the soft tissue sarcoma committee of the children's oncology group (2004) (199)
- TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance. (1997) (196)
- Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19). (1990) (194)
- Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. (1993) (193)
- Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG. (2001) (191)
- Pre-B cell leukemia associated with chromosome translocation 1;19. (1984) (190)
- Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations. (1991) (189)
- Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. (1994) (187)
- Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse. (1991) (179)
- Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12 000 randomised children (1996) (177)
- Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study (1990) (176)
- Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia. (1995) (164)
- Biology and treatment of acute lymphoblastic leukemia. (1994) (156)
- Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. (2000) (152)
- Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's O (2011) (149)
- Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia. (1997) (148)
- Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia. (1990) (146)
- An analysis of leukemic cell chromosomal features in infants. (1987) (142)
- Hypodiploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia. (1987) (137)
- Monoclonal antibody characterization of surface antigens in childhood T-cell lymphoid malignancies. (1983) (131)
- Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: Report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991. (2000) (128)
- What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? (2001) (127)
- Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome. (1996) (126)
- Lymphatic metastases with childhood rhabdomyosarcoma. A report from the intergroup rhabdomyosarcoma study (1987) (125)
- Expression of the multidrug resistance, MDR1, gene in neuroblastomas. (1990) (124)
- Fatal Epstein-Barr virus-associated hemophagocytic syndrome. (1981) (114)
- Increased mortality after successful treatment for Hodgkin's disease. (1998) (113)
- Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an intergroup rhabdomyosarcoma study. (2001) (112)
- Myeloid neoplasia in children treated for solid tumours (1990) (111)
- Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997). (2000) (109)
- Clinical features and treatment outcome for children with CD30+ large-cell non-Hodgkin's lymphoma. (1994) (108)
- Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997. (2002) (107)
- Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19) (q23; p13) or its derivative. (1994) (107)
- Pre-B cell leukemia responds poorly to treatment: a pediatric oncology group study. (1984) (106)
- Correlation of karyotype and immunophenotype in childhood acute lymphoblastic leukemia. (1988) (103)
- High serum interleukin-2 receptor levels are related to advanced disease and a poor outcome in childhood non-Hodgkin's lymphoma. (1987) (102)
- Clinicopathologic features and treatment outcome of children with large-cell lymphoma and the t(2;5)(p23;q35). (1994) (102)
- Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma? (2001) (102)
- New recurring chromosomal translocations in childhood acute lymphoblastic leukemia. (1991) (100)
- Prognostic importance of structural chromosomal abnormalities in children with hyperdiploid (greater than 50 chromosomes) acute lymphoblastic leukemia. (1989) (99)
- Near-triploid and near-tetraploid acute lymphoblastic leukemia of childhood. (1990) (98)
- Primary and metastatic rhabdomyosarcoma in the breast: neoplasms of adolescent females, a report from the Intergroup Rhabdomyosarcoma Study. (1997) (98)
- Rhabdomyosarcoma. Biology and treatment. (1997) (95)
- Acute Lymphoblastic Leukemia in a Developing Country: Preliminary Results of a Nonrandomized Clinical Trial in El Salvador (2000) (95)
- Clinical presentation, karyotypic characterization, and treatment outcome of childhood acute lymphoblastic leukemia with a near-haploid or hypodiploid less than 45 line (1990) (94)
- Prognosis of children with soft tissue sarcoma who relapse after achieving a complete response. A report from the intergroup rhabdomyosarcoma study I (2006) (92)
- Outcome of treatment for childhood cancer in black as compared with white children. The St Jude Children's Research Hospital experience, 1962 through 1992. (1995) (91)
- Prognostic importance of the pre-B-cell immunophenotype and other presenting features in B-lineage childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. (1989) (90)
- Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III. (1999) (90)
- Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma. (2000) (90)
- Lack of association between abnormalities of the chromosome 9 short arm and either "lymphomatous" features or T cell phenotype in childhood acute lymphocytic leukemia. (1987) (84)
- Prognostic factors in the acute lymphoid and myeloid leukemias of infants. (1996) (83)
- Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. (1990) (80)
- Clinical significance of CD10 expression in childhood acute lymphoblastic leukemia. (1993) (79)
- Individualized dosages of chemotherapy as a strategy to improve response for acute lymphocytic leukemia. (1991) (78)
- Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study. (1990) (78)
- Philadelphia chromosome-positive acute lymphoblastic leukemia in children: durable responses to chemotherapy associated with low initial white blood cell counts (1997) (77)
- Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. (1990) (75)
- Serum interleukin 2 receptor levels in childhood acute lymphoblastic leukemia. (1988) (74)
- Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy (1990) (74)
- Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: the St Jude Children's Research Hospital experience, 1962 to 1988. (1991) (73)
- Efficacy of ifosfamide and doxorubicin given as a phase II "window" in children with newly diagnosed metastatic rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. (2001) (73)
- Ifosfamide and Etoposide Are Superior to Vincristine and Melphalan for Pediatric Metastatic Rhabdomyosarcoma When Administered With Irradiation and Combination Chemotherapy: A Report From the Intergroup Rhabdomyosarcoma Study Group (2001) (72)
- Pediatric oncology group experience with modified LSA2‐L2 therapy in 107 children with non‐Hodgkin's lymphoma (Burkitt's lymphoma excluded) (1985) (71)
- Role of High-Dose Chemotherapy With Hematopoietic Stem Cell Rescue in the Treatment of Metastatic or Recurrent Rhabdomyosarcoma (2001) (71)
- Retroperitoneal node biopsy in paratesticular rhabdomyosarcoma. (1994) (70)
- An intensive re-treatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia. (1995) (69)
- Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group study. (1992) (69)
- Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV. (2003) (68)
- Rhabdomyosarcoma of the biliary tree in childhood. A report from the intergroup rhabdomyosarcoma study (1985) (67)
- Clinical staging and treatment results in rhabdomyosarcoma of the female genital tract among children and adolescents (1988) (66)
- Progress in the surgical management of vaginal rhabdomyosarcoma: a 25-year review from the Intergroup Rhabdomyosarcoma Study Group. (1999) (65)
- Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia. (1996) (64)
- Sarcomas of the vagina and uterus: the Intergroup Rhabdomyosarcoma Study. (1985) (63)
- Etoposide achieves potentially cytotoxic concentrations in CSF of children with acute lymphoblastic leukemia. (1996) (62)
- Clinical characteristics and treatment outcome of children with acute lymphocytic leukemia and down's syndrome. A pediatric oncology group study (1991) (61)
- The cytosine arabinoside (Ara-C) syndrome. (1981) (60)
- Clinical presentation, karyotypic characterization, and treatment outcome of childhood acute lymphoblastic leukemia with a near-haploid or hypodiploid less than 45 line. (1990) (59)
- Molecular evidence for minimal residual bone marrow disease in children with 'isolated' extra-medullary relapse of T-cell acute lymphoblastic leukemia. (1994) (58)
- Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group. (2001) (57)
- Acute megakaryoblastic leukemia in children and adolescents: a retrospective analysis of 24 cases. (1993) (56)
- Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. (1990) (54)
- Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. (2004) (54)
- Intrathoracic soft tissue sarcomas in children (1982) (54)
- The t(10;14)(q24;q11) of T-cell acute lymphoblastic leukemia juxtaposes the delta T-cell receptor with TCL3, a conserved and activated locus at 10q24. (1990) (53)
- Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. (1994) (51)
- The French—American—British (FAB) classification of leukemia. The pediatric oncology group experience with lymphocytic leukemia (1986) (49)
- Pediatric Oncology Group Utilization of Immunologic Markers in the Designation of Acute Lymphocytic Leukemia Subgroups: Influence on Treatment Response a (1984) (48)
- Primary chemotherapy in the treatment of children with bladder-prostate tumors in the intergroup rhabdomyosarcoma study (IRS-II) (1982) (47)
- Surgical implications of primary gastrointestinal lymphoma of childhood. (1990) (46)
- Risk of adverse events in children completing treatment for acute lymphoblastic leukemia: St. Jude Total Therapy studies VIII, IX, and X. (1991) (46)
- Increased serum CD8 antigen level in childhood Hodgkin's disease relates to advanced stage and poor treatment outcome. (1989) (46)
- An altered 11-kilobase transcript in leukemic cell lines with the t(4;11)(q21;q23) chromosome translocation. (1992) (46)
- Cyclophosphamide Dose Intensification during Induction Therapy for Intermediate-Risk Pediatric Rhabdomyosarcoma Is Feasible but Does Not Improve Outcome (2004) (45)
- Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency. (1993) (45)
- Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997. (2003) (45)
- Partial cystectomy in the management of rhabdomyosarcoma of the bladder: a report from the Intergroup Rhabdomyosarcoma Study. (1990) (45)
- High serum interleukin-2 receptor levels correlate with a poor prognosis in children with Hodgkin's disease. (1989) (44)
- Serum intercellular adhesion molecule-1 in childhood malignancy. (1993) (44)
- Hypersensitivity reactions to epipodophyllotoxins in children with acute lymphoblastic leukemia (1991) (44)
- Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell activity in poor-risk patients. (1988) (44)
- Immunologic and clinicopathologic features of common acute lymphoblastic leukemia antigen‐positive childhood T‐cell leukemia A pediatric oncology group study (1987) (44)
- Clinicopathologic Study of Ectomesenchymomas from Intergroup Rhabdomyosarcoma Study Groups III and IV (2000) (43)
- High risk lymphoblastic leukemia in children: prognostic factors and management. (1987) (42)
- P-glycoprotein expression at diagnosis may not be a primary mechanism of therapeutic failure in childhood rhabdomyosarcoma. (1996) (42)
- Cytogenetic abnormalities in childhood acute lymphoblastic leukemia correlates with clinical features and treatment outcome. (1992) (41)
- Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission (2000) (41)
- Tumor-cell DNA content predicts outcome in children and adolescents with clinical group III embryonal rhabdomyosarcoma. The Intergroup Rhabdomyosarcoma Study Committee of the Children's Cancer Group and the Pediatric Oncology Group. (1993) (40)
- Bilateral Wilms' tumor. A review (1972) (40)
- Intensive chemotherapy for metastatic neuroblastoma: a Southwest Oncology Group study. (1980) (40)
- Results of intensive therapy in children with localized alveolar extremity rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study. (1989) (39)
- Clinical and biological heterogeneity of childhood B cell acute lymphocytic leukemia: implications for clinical trials. (1990) (38)
- Treatment intensity and outcome for children with acute lymphocytic leukemia of standard risk. A pediatric oncology group study (1989) (38)
- CNS involvement in children with newly diagnosed non-Hodgkin's lymphoma. (2000) (38)
- A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma (1993) (38)
- Soft tissue sarcomas arising in the retroperitoneal space in children a report from the intergroup rhabdomyosarcoma study (IRS) committee (1985) (37)
- Improved outcome for patients with middle ear rhabdomyosarcoma: a children's oncology group study. (2001) (36)
- Isochromosomes in childhood acute lymphoblastic leukemia: a collaborative study of 83 cases. (1992) (35)
- Human t(4;11)(q21;q23) acute lymphoblastic leukemia in mice with severe combined immunodeficiency. (1994) (34)
- Uniform criteria for childhood acute lymphoblastic leukemia risk classification. (1996) (34)
- Phase I study of oral etoposide in children with refractory solid tumors. (1994) (33)
- Predictive ability of lukes‐collins classification for immunologic phenotypes of childhood non‐Hodgkin lymphoma: An institutional series and literature review (1981) (33)
- Soft tissue sarcoma of the perineal region in childhood. A report from the intergroup rhabdomyosarcoma studies I and II, 1972 through 1984 (1990) (33)
- Surgical Principles for Children/Adolescents With Newly Diagnosed Rhabdomyosarcoma: A Report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group (2002) (32)
- Granulocytic sarcoma with an indolent course and destructive skeletal disease. Tumor characterization with immunologic markers, electron microscopy, cytochemistry, and cytogenetic studies (1986) (32)
- Erythropoietin--not yet a standard treatment for anemia of prematurity. (1995) (31)
- Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. A pediatric oncology group study (1991) (30)
- Clonal analysis of childhood acute lymphoblastic leukemia with "cytogenetically independent" cell populations. (1989) (30)
- Presenting features and treatment outcome of adolescents with acute lymphoblastic leukemia. (1990) (30)
- Phase I study of cytokine-gene modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma. (1992) (30)
- Clinical features and results of therapy for children with paraspinal soft tissue sarcoma: a report of the Intergroup Rhabdomyosarcoma Study. (1991) (30)
- Acute leukemia and hypopyon. (1978) (30)
- Results of treatment of fifty‐six patients with localized retroperitoneal and pelvic rhabdomyosarcoma: A report from The Intergroup Rhabdomyosarcoma Study‐IV, 1991–1997 (2004) (30)
- Immunoglobulin heavy-chain switching in pre-B leukaemias (1983) (29)
- G19.4(alpha CD3) x B43(alpha CD19) monoclonal antibody heteroconjugate triggers CD19 antigen-specific lysis of t(4;11) acute lymphoblastic leukemia cells by activated CD3 antigen-positive cytotoxic T cells. (1992) (29)
- Does debulking improve survival rate in advanced-stage retroperitoneal embryonal rhabdomyosarcoma? (1999) (28)
- Isochromosomes in Childhood Acute Lymphoblastic Leukemia: A Collaborative Study of 83 Cases (1992) (28)
- Children from ethnic minorities have benefited equally as other children from contemporary therapy for rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. (2002) (28)
- Laboratory correlates and prognostic significance of granular acute lymphoblastic leukemia in children. A Pediatric Oncology Group study. (1991) (28)
- The argument for conservative, delayed surgery in the management of prostatic rhabdomyosarcoma. (1996) (27)
- A Phase II Trial of High‐Dose Methotrexate in Previously Untreated Children and Adolescents with High‐Risk Unresectable or Metastatic Rhabdomyosarcoma (1997) (26)
- A comparison of two regimens for high‐risk acute lymphocytic leukemia in childhood. A pediatric oncology group study (1989) (26)
- Continuous infusion of interleukin‐2 in children with refractory malignancies (1993) (26)
- Sideroblastic anemia associated with thrombocytosis and a chromosome 3 abnormality. (1986) (26)
- Rhabdomyosarcoma of the parotid region occurring in childhood and adolescence (2001) (26)
- Severe congenital leukopenia (reticular dysgenesis). Immunologic and morphologic characterizations of leukocytes. (1985) (25)
- Effect of trimethoprim/sulfamethoxazole prophylaxis on outcome of childhood lymphocytic leukemia a pediatric oncology group study (1987) (25)
- Adjuvant chemotherapy in nonmetastatic osteosarcoma: a Southwest Oncology Group Study. (1980) (25)
- Impact of tumor viability at second-look procedures performed before completing treatment on the Intergroup Rhabdomyosarcoma Study Group protocol IRS-IV, 1991-1997: a report from the children's oncology group. (2010) (25)
- Chemotherapy of childhood medulloblastoma. (1976) (25)
- Clinical and biologic features of childhood T-cell leukemia with the t(11;14) (1991) (25)
- Progress in the treatment of adolescents with acute lymphoblastic leukemia (1993) (25)
- Childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): an update [letter] (1994) (24)
- Effects of recombinant human hematopoietic growth factors on leukemic blasts from children with acute myeloblastic or lymphoblastic leukemia. (1993) (24)
- Treatment of childhood leukemias. (1995) (23)
- Secondary surgical procedures to evaluate primary tumor status in patients with chemotherapy-responsive stage III and IV sarcomas: a report from the Intergroup Rhabdomyosarcoma Study. (1990) (22)
- Granulocyte colony-stimulating factor corrects the neutropenia associated with glycogen storage disease type Ib. (1991) (22)
- Serum CD4, CD8, and interleukin-2 receptor levels in childhood acute myeloid leukemia. (1991) (21)
- Soft-Tissue Sarcomas of the Diaphragm: A Report From the Intergroup Rhabdomyosarcoma Study Group From 1972 to 1997 (2000) (21)
- Intensive chemotherapy including cisplatin with or without etoposide for children with soft-tissue sarcomas. (1987) (20)
- Phase I study of recombinant human interferon gamma in children with relapsed acute leukemia. (1992) (20)
- Epipodophyllotoxins in the treatment of childhood cancer (2004) (19)
- Secondary non-Hodgkin's lymphoma after treatment for childhood cancer. (1991) (18)
- Pre-B-Cell Acute Lymphoblastic Leukemia in Childhood. (1990) (18)
- Adverse prognostic features in 251 children treated for acute myeloid leukemia. (1993) (18)
- Serum interleukin-2 receptor levels in Hodgkin disease and other solid tumors of childhood. (1993) (18)
- Lymphoblastic conversion in chronic myelogenous leukemia. (1978) (17)
- Vicinal glycol‐staining identifies secondary granules in human normal and chédiak‐higashi neutrophils (1983) (17)
- Hereditary Pyropoikilocytosis and Elliptocytosis: Clinical, Laboratory, and Ultrastructural Features in Infants and Children (1982) (17)
- St Jude Children's Research Hospital's International Outreach Program. (1996) (17)
- A pilot study of intermediate‐dose methotrexate and cytosine arabinoside, “Spread‐out” or “Up‐front,” in continuation therapy for childhood non‐T, non‐B acute lymphoblastic leukemia a pediatric oncology group study (1991) (17)
- Simultaneous expression of RBTN-2 and BCR-ABL oncogenes in a T-ALL with a t(11;14)(p13;q11) and a late-appearing Philadelphia chromosome. (1994) (16)
- Toward a clinically useful classification of the acute leukemias. (1995) (16)
- Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study. (1992) (16)
- The translocation (1;14)(p34;q11) in human t‐cell leukemia: Chromosome breakage 25 kilobase pairs downstream of the tal1 protooncogene (1992) (16)
- Management of localized thoracic neuroblastoma. (1979) (16)
- Clinical and biologic features of childhood T-cell leukemia with the t(11;14). (1991) (15)
- Childhood acute myeloid leukemia in mice with severe combined immunodeficiency. (1994) (15)
- Pleural effusion is associated with a poor treatment outcome in stage III small non-cleaved cell lymphoma. (1991) (15)
- Granulopoiesis in childhood aplastic anemia. (1976) (15)
- Phagocytosis of neutrophils by marrow macrophages in childhood chronic benign neutropenia. (1981) (15)
- Update of St Jude Study XI for childhood acute lymphoblastic leukemia. (1992) (14)
- Dysgranulopoietic neutropenia and abnormal monocytes in childhood vitamin B12 deficiency (1980) (14)
- Aspergillus osteomyelitis in a child treated for acute lymphoblastic leukemia (1990) (14)
- Overt testicular disease at diagnosis is associated with high risk features and a poor prognosis in patients with childhood acute lymphoblastic leukemia (1996) (13)
- Web-based decision support for clinical trial eligibility determination in an international clinical trials network. (2003) (13)
- Granulopoiesis in osteopetrosis. (1975) (12)
- Clinicopathologic Features and Treatment Outcome of Children With Large-Cell Lymphoma and the t ( 2 ; 5 ) ( p 23 ; q 35 ) (2002) (12)
- Childhood Acute Myeloid Leukemia in Mice With Severe Combined Immunodeficiency (1994) (12)
- Loffler's endomyocardial fibrosis, eosinophilia, and acute lymphoblastic leukemia. (1977) (12)
- Morphologic discordance in acute leukemia. (1972) (11)
- Down-regulated c-myb expression inhibits DNA synthesis of T-leukemia cells in most patients. (1990) (11)
- Rhabdomyosarcoma diagnosed by electron microscopy in a child with acute lymphocytic leukemia. (1978) (11)
- Properdin factor B and acute lymphocytic leukemia (ALL) (1982) (11)
- Childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): an update. (1994) (11)
- Rhabdoid tumor of the kidney: complete remission induced by cis-platinum and adriamycin. (1981) (10)
- XYY syndrome in children with acute lymphoblastic leukemia. (1997) (10)
- Secondary leukaemias after epipodophyllotoxins (1992) (9)
- Clinical implications of cytogenetic and molecular analyses of pediatric acute lymphoblastic leukemia (1993) (9)
- What comprises appropriate therapy for children/adolescents with rhabdomyosarcoma arising in the abdominal wall? A report from the Intergroup Rhabdomyosarcoma Study Group. (1999) (9)
- CYTOGENETICS OF B-CELL LINEAGE ACUTE LYMPHOCYTIC LEUKAEMIAS OF CHILDHOOD (1982) (9)
- Systemic hemophagocytosis masking the diagnosis of large cell non-Hodgkin lymphoma. (1997) (8)
- Teniposide (VM‐26) and continuous infusion cytosine arabinoside for initial induction failure in childhood acute lymphoblastic leukemia. A pediatric oncology group pilot study (1990) (8)
- Factors contributing to the prognostic significance of bone marrow involvement in childhood non-Hodgkin lymphoma. (1994) (8)
- The epipodophyllotoxins: both sides of the coin. (1993) (8)
- Current Treatment and Results of St. Jude Studies for Childhood Acute Lymphoblastic Leukemia (1994) (8)
- Results from the IRS IV randomized trial of hyperfractionated radiation in children with rhabdomyosarcoma (2000) (7)
- Prognostic factors and outcome in children with metastatic rhabdomyosarcoma - a report from the intergroup rhabdomyosarcoma study IV (2001) (7)
- Staging systems in neuroblastoma: which is best? (1991) (6)
- Extranodal primary tumor site indicates poor prognosis in childhood head and neck non-Hodgkin's lymphomas. (1991) (6)
- Management of infections. (1983) (6)
- Heterogeneity of the breakpoint localization in malignant cells with a 9p11 chromosomal abnormality. (1991) (6)
- 960 THE ACCURACY OF IDENTIFYING T CELL LEUKEMIA USING E ROSETTING OF BONE MARROW LYMPHOBLASTS (1981) (5)
- A pilot study of intermediate-dose methotrexate and cytosine arabinoside, "spread-out" or "up-front," in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia. A Pediatric Oncology Group study. (1991) (5)
- Large proportion of Epstein-Barr virus-associated small noncleaved cell lymphomas among children with non-Hodgkin's lymphoma at a single institution in Moscow, Russia. (1999) (5)
- Acute Lymphocytic Leukemia in Childhood: Immunologic Marker, Cytogenetic, and Molecular Studies (1987) (4)
- Granulopoiesis in chronic myeloproliferative disorders in children. (1978) (4)
- CELLULAR EXPRESSION OF WISKOTT-ALDRICH ALLELE (1980) (4)
- Primary chemotherapy in the treatment of children with bladder--prostate tumors in the Intergroup Rhabdomyosarcoma Study (IRS-II). (1983) (4)
- Neuroblastoma "Leukemia"—a Rarity? (1978) (4)
- Acute lymphocytic leukemia of childhood: The problems of relapses (1989) (4)
- Soft tissue sarcoma of the perineal anal region in childhood a report from the intergroup rhabdomyosarcoma study committee (1986) (3)
- Transient Myeloid Dysplasia Due to Valproic Acid (1997) (3)
- Diagnosis and treatment of the most common solid tumors in childhood. (1992) (3)
- Risk-Adapted Treatment for Acute Lymphoblastic Leukemia: Findings from St. Jude Children’s Research Hospital (1997) (3)
- Case report: Sinus histiocytosis with massive lymphadenopathy (1980) (3)
- Prevention of Pneumocystis carinii pneumonia in children with cancer. (1994) (2)
- Clinical Characteristics and Treatment Outcome of Childhood Acute Lymphoblastic Leukemia With the t ( 4 ; l l ) ( q 21 ; q 23 ) : A Collaborative Study of 40 Cases (2003) (2)
- A Review of Evidence that the Feline Leukemia Virus (FeLV) might be causative in Childhood Acute Lymphocytic Leukemia (ALL) (1983) (2)
- Intranuclear crystalloids associated with abnormal granules in eosinophilic leukocytes (1981) (2)
- Intranuclear crystalloids associated with abnormal granules in eosinophilic leukocytes. (1981) (2)
- Low-dose adriamycin remission maintenance for advanced acute lymphoblastic leukemia: a Southwest Oncology, Group study. (1981) (2)
- Hypersplenism in a child with acute lymphatic leukemia (1973) (2)
- Acute Lymphoid Leukemia Outcomes in Black and White Children-Reply (1995) (2)
- Giant actin inclusions in hematopoietic cells associated with transfusion-dependent anemia and grey skin discoloration. (1994) (2)
- NORMAL AND ABERRANT B-CELL DIFFERENTIATION IN BONE MARROW (1977) (1)
- Does radiotherapy improve the cure rate of children/adolescents with completely resected rhabdomyosarcoma who are also treated with chemotherapy? (1998) (1)
- 850 THYMOCYTE ANTIGEN IN T CELL LEUKEMIA (1981) (1)
- Unusual translocations t(2;6) and t(?;22) in a child with acute myelocytic leukemia. (1983) (1)
- Childhood neutropenia. (1982) (1)
- Leukemias and lymphomas in children. (1992) (1)
- #407 Children from ethnic minorities have benefited equally as other children from contemporary therapy for rhabdomyosarcoma (RMS): a report from the intergroup rhabdomyosarcoma study group (IRSG) (1999) (1)
- DNA fragments of altered electrophoretic mobility in leukemia samples can arise from double-strand DNA breaks at nuclease hypersensitive sites of active genes. (1993) (1)
- Myelopoiesis in immunologically classified subgroups of childhood acute lymphocytic leukemia. (1980) (1)
- Genetic predisposition to acute lymphocytic leukemia in American blacks. A pediatric oncology group study (1985) (1)
- Cleary coding sequences in acute lymphoblastic leukemias (0)
- A vision for the University of Missouri-Columbia School of Medicine. (2001) (0)
- Clinical and biological features predict relapse hazard in childhood acute lymphoid leukemia. (1988) (0)
- Group Experience with Immunological Phenotyping in Acute Lymphocytic Leukemia of Childhood 1 (2006) (0)
- The role of myeloablative chemotherapy with stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma (2000) (0)
- Therapy of Childhood Leukemia: Understanding Success and Failure (1991) (0)
- Clinical Features and Outcome of T-cell Acute Lymphoblastic Leukemia in Childhood With Respect to Alterations at the T A L l Locus: A Pediatric Oncology Group Study (2003) (0)
- Lymphoblastic Conversion in Chronic Myelogenous Leukemia (1978) (0)
- DISTURBANCES OF GRANULOPOIESIS IN CONGENITAL CYTOMEGALOVIRUS (CMV) INFECTION (1977) (0)
- Relationship between chemical-induced fragile sites and chromosomal breakpoints in malignant cells in children. (1992) (0)
- Vote YES on the Missouri stem cell research and cures initiative. (2006) (0)
- Witnessing a metamorphosis of medicine at MU. (2007) (0)
- Humoral factors in the regulation of granulopoiesis. Abstr. (1975) (0)
- INTRAN UCLEAR CRYSTALLOIDS IN EOSINOPHILS 1 135 from patient monocytes and serum (2005) (0)
- Treatment o f L ocalized N onorbital, N onparameningeal H ead and N eck R habdomyosarcoma : L essons L earned F rom Intergroup R habdomyosarcoma S tudies I II a nd I V (2003) (0)
- Biology and staging of childhood non-Hodgkin lymphoma. (1988) (0)
- Funding for medicine at UMC would benefit all Missourians. (2006) (0)
- Intergroup R habdomyosarcoma S tudy-IV: R esults f or Patients W ith N onmetastatic D isease (2001) (0)
- patients possible indicator of increased suppressor cell activity in poor-risk Serum levels of CD8 antigen in childhood lymphoid malignancies: a (2011) (0)
- Hypersplenism in a child with acute lymphatic leukemia. (1973) (0)
- Prognostic F actors a nd C linical O utcomes i n C hildren a nd Adolescents W ith M etastatic R habdomyosarcoma —A R eport From t he I ntergroup R habdomyosarcoma S tudy I V (2003) (0)
- TREATMENT OF RHABDOMYOSARCOMA. AUTHORS' REPLY (1996) (0)
- ACQUIRED AGRANULOCYTOSIS SECONDARY TO A SERUM INHIBITOR (1977) (0)
- Is Associated With a Poor Prognosis in Childhood Acute Lymphoblastic Leukemia (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With William M. Crist?
William M. Crist is affiliated with the following schools:
